Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease
TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland) has…
A Global Crisis in Basic Eye Care: Millions Still Struggling Without Glasses
Global access to eye glasses is at 65.8%—barely up since 2010 and far below WHO’s 2030 goal. A new study…
popular posts
latest posts
